Cardiorenal

Bringing better medicine to patients

Science sourced worldwide

There are over 290 million people in China with cardiovascular disease and more than 100 million with chronic kidney disease. Cardiorenal disease is the leading cause of death in China today.

Mavacamten

Cardiorenal

Mavacamten is a first-in-class small molecule therapeutic that reversibly binds to myosin to directly target the excess contractility and impaired relaxation underlying hypertrophic cardiomyopathy, or HCM.

Phase 3

arrow-btn